This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
RAN-GABAPENTIN (2015-04-10)
- Starting date:
- April 10, 2015
- Posting date:
- April 14, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-52913
Recalled Products
RAN-Gabapentin
Reason
Possibility of contamination with trace amounts of the active ingredient Etodolac.
Depth of distribution
Retailers
Affected products
RAN-Gabapentin
DIN, NPN, DIN-HIM
DIN 02319055
Dosage form
Capsule
Strength
Gabapentin 100 mg
Lot or serial number
2582026
Companies
- Recalling Firm
-
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
- Marketing Authorization Holder
-
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
Related AWRs
